¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reduction in area"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • barium reduction
    ¹Ù·ýÁ¤º¹(¼ú)
  • breast reduction
    À¯¹æÁÙÀÓ(¼ú), À¯¹æÃà¼Ò(¼ú)
  • closed reduction
    ºñ°³¹æÁ¤º¹(¼ú), Æó¼âÁ¤º¹(¼ú)
  • forehead reduction
    À̸¶Ãà¼Ò(¼ú), À̸¶¼ºÇü(¼ú)
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò(¼ú), ÇϾǰ¢Ãà¼Ò(¼ú)
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • open reduction
    °³¹æÁ¤º¹(¼ú)
  • oxidation-reduction
    »êȭȯ¿ø
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
  • oxidation-reduction system
    »êȭȯ¿ø°è
  • proportional reduction
    ºñ·Ê°¨¼Ò
  • reduction
    1. ¸ÂÃã, ±³Á¤, Á¤º¹(¼ú) 2. ȯ¿ø 3. Ãà¼Ò(¼ú) 4. ¾àºÐ
  • reduction division
    °¨¼öºÐ¿­
  • reduction potential
    ȯ¿øÀüÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • area
    ±¸¿ª, ¿µ¿ª, ¿ª, ºÎÀ§, ºÎ, ¸éÀû
  • area cribrosa
    ü±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • inguinal area
    »ô±¼ºÎÀ§, ¼­ÇýºÎ
  • preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
  • subareolar area
    Á¥²ÉÆÇ¹ØºÎÀ§, À¯·ûÇϺÎ
  • supporting area
    ÁöÁöºÎ
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
  • oxidation-reduction
    »êȭȯ¿ø
  • reduction
    1.¸ÂÃã, ±³Á¤, Á¤º¹, 2.ȯ¿ø, Ãà¼Ò
  • barium reduction
    ¹Ù·ý±³Á¤¼ú
  • breast reduction
    À¯¹æÁÙÀÓ¼ú, À¯¹æÃà¼Ò¼ú
  • closed reduction
    ºñ°³¹æ±³Á¤(¼ú)
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò¼ú, ÇϾǰ¢Ãà¼Ò¼ú
  • open reduction
    °³¹æ±³Á¤(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • breast reduction
    À¯¹æÁÙÀÓ¼ú, À¯¹æÃà¼Ò¼ú
  • closed reduction
    Æó¼â°ñÀý±³Á¤, Æó¼âµÇ¸ÂÃã¼ú
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • forehead reduction
    À̸¶»è°¨¼ú, À̸¶¼ºÇü¼ú
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò¼ú, ÇϾǰ¢Ãà¼Ò¼ú
  • silver reduction method
    ÀºÈ¯¿ø¹ý
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • oxidation-reduction
    »êȭȯ¿ø
  • open reduction
    °³¹æ°ñÀý±³Á¤, ¿­¸²µÇ¸ÂÃã¼ú
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
  • oxidation-reduction system
    »êȭȯ¿ø°è
  • oxidation-reduction titration
    »êȭȯ¿øÀûÁ¤
  • proportional reduction
    ºñ·Ê°¨·Â
  • reduction potential
    ȯ¿øÀüÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plaque reduction neutralization test
    ÇöóÅ© °¨¼ÒÁßÈ­½ÃÇè
  • plaque reduction test
    ÇöóÅ© °¨¼Ò½ÃÇè
  • pock reduction test
    Æø °¨¼ÒÁßÈ­½ÃÇè
  • reduction
    Á¤º¹¼ú, °¨¼Ò, Ãà¼Ò
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction discharge
    ȯ¿ø¼º¹æ.
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ).
  • reduction division
    °¨¼öºÐ¿­
  • reduction division
    °¨¼öºÐ¿­
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • reduction of chromosome
    ¿°»öü°¨¼ö(æøßäô÷Êõâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
  • reduction potential
    ȯ¿øÀüÀ§.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cochlear area, =area cochleae <³ª>
    ¿Í¿ì¿µ¿ª, ´ÞÆØÀ̽Ű汸¿ª{ÇØ}
  • cochlear area<³ª> area cochleae
    ´ÞÆØÀ̽Ű汸¿ª, ¿Í¿ì¾ß(èÄéÚå¯).
  • supplemental motor area = supplementary area
    º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´)
  • closed reduction
    µµ¼öÁ¤º¹(Óùâ¢ïÚÜÙ), ºñ°üÇ÷Àû(°ñ)Á¤º¹¼ú(ުκúìîÜÍéïÚÜÖâú).
  • copper reduction test
    ±¸¸®È¯¿ø½ÃÇè
  • dose-reduction factor
    ¼±·®°¨¼Ò°è¼ö
  • false reduction
    °¡ ȯ³³(Ê£ü½Ò¡), °¡ Á¤º¹.
  • methylene blue reduction test
    ¸ÞÆ¿·»ºí·ç ¿ìȯ¿ø½ÃÇè(¡­ü»êªãËúÐ).
  • nitrate reduction
    Áú»ê¿°È¯¿ø(òòß«ç¤ü½êª).
  • nitrate reduction test
    Áú»ê¿°È¯¿ø½ÃÇè(~ãËúÐ).
  • open reduction
    °³¹æ¼º Á¤º¹(ËÒÛ¯àõïÚÜÖ), °üÇ÷Àû Á¤º¹ °ñÀý(κúìîÜïÚÜÖÍéï¹), ~ÀÇ .
  • oxidation reduction potential
    »êÈ­-ȯ¿øÀüÀ§
  • oxidation reduction potential =redox p.
    »êȭȯ¿øÀüÀ§.
  • oxidation reduction system =redox s.
    »ê ȭȯ¿ø°è.
  • oxidation reduction titration =redox t.
    »ê ȭȯ¿øÀûÁ¤(¡­îÙïÒ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Reduction division
    °¨¼öºÐ¿­
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­
  • Marginal area
    °¡ÀåÀÚ¸®±¸¿ª
    [¿¾ ¿ë¾î] º¯¿¬ºÎ
  • Cupula area
    ²À´ë±â±¸¿ª
    [¿¾ ¿ë¾î] ¹èºÎ
  • Subcallosal area
    ³úµéº¸¹Ø±¸¿ª
    [¿¾ ¿ë¾î] ¾çÇϾß
  • Cochlear area
    ´ÞÆØÀ̽Ű汸¿ª
    [¿¾ ¿ë¾î] ¿Í¿ì¾ß
  • Contact area
    ´ê´ÂºÎºÐ
    [¿¾ ¿ë¾î] Á¢Ã˸é
  • Posterior intercondylar area
    µÚÀ¶±â»çÀ̱¸¿ª
    [¿¾ ¿ë¾î] Èİú°£±¸
  • Area postrema
    ¸Ç¾Æ·¡±¸¿ª
    [¿¾ ¿ë¾î] ÃÖÇϾß
  • Bare area
    ¹«À帷±¸¿ª
    [¿¾ ¿ë¾î] ¹«À帷¾ß
  • Opaque area
    ºÒÅõ¸í±¸¿ª
    [¿¾ ¿ë¾î] ¾Ï¾ß[ºÎ]
  • Vesiclular area
    ¼ÒÆ÷±¸¿ª
    [¿¾ ¿ë¾î] ¼ÒÆ÷ºÎ
  • Preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
    [¿¾ ¿ë¾î] ½Ã½Å°æ±³Â÷Àü¾ß
  • Cardiogenic area
    ½ÉÀå¹ß»ý±¸¿ª
    [¿¾ ¿ë¾î] ½ÉÀå¹ß»ý±¸¿ª
  • Inferior vestibular area
    ¾Æ·¡¾È¶ã½Å°æ±¸¿ª
    [¿¾ ¿ë¾î] ÇÏÀüÁ¤¾ß
  • Vestibular area
    ¾È¶ã±¸¿ª
    [¿¾ ¿ë¾î] ÀüÁ¤½Å°æ¾ß
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
  • hyperendemic area
    °íµµÀ¯ÇàÁö
  • hypoendemic area
    ÀúµµÀ¯ÇàÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • assimilatory reduction
    µ¿È­Àûȯ¿ø (ÔÒûùîÜü½êª)
  • biological oxidation-reduction
    »ýü »êȭȯ¿ø(ßæô÷ß«ûùü½êª)
  • carbon reduction cycle
    ź¼Ò ȯ¿ø ȸ·Î(÷©áÈü½êªüÞÖØ)
  • catalytic reduction method
    Ã˸Åȯ¿ø¹ý(õºØÚü½êªÛö)
  • dissimilatory reduction
    ÀÌÈ­ ȯ¿ø(ì¶ûùü½êª)
  • nitrate reduction
    Áú»êȯ¿ø(òòß«ü½êª)
  • oxidation-reduction enzyme
    »êȭȯ¿ø È¿¼Ò(ß«ûùü½êªý£áÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • oxidation-reduction reaction
    »êȭȯ¿ø ¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • plaque reduction method
    ÇöóÅ© °¨¼Ò¹ý(Êõá´Ûö)
  • reduction
    "ȯ¿ø(ü½êª), °¨¼Ò(Êõá´)"
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ)
  • reduction phase
    ȯ¿ø±â(ü½êªÑ¢)
  • reduction potential
    ȯ¿ø ÀüÀ§(ü½êªï³êÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • open reduction
    °üÇ÷ÀûÁ¤º¹
  • reduction
    Á¤º¹, °¨¼Ò, ȯ¿ø
  • reduction of fracture
    °ñÀýÁ¤º¹
  • adjacent area
    ÀÎÁ¢¿ª
  • area
    ¿µ¿ª, ¾ß, Áö¿ª, ±¸
  • bare area
    ³ëÃâºÎ
  • Broca's area
    ºê·ÎÄ«¿µ¿ª
  • high echo area
    °í¿¡ÄÚ ±¸¿ª
  • LAN [=local area network]
    ±Ù°Å¸®Åë½Å¸Á, ·£
  • Lor-fitted area
    Ãִ뿵¿ª
  • low echo area
    Àú¿¡ÄÚ±¸¿ª
  • motor speech area
    ¿îµ¿¾ð¾î·É
  • postcricoid area
    À±»ó¿¬°ñÈĺÎ
  • posterior hypothalamic area
    ÈĽûóÇϺοµ¿ª
  • premotor area
    Àü¿îµ¿¿µ¿ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
LA50 total body surface area of burn that will kill 50% of patients (lethal area)
CR   1) Complete Response
  2) Close Reduction
C/R Close Reduction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ARR Absolute risk reduction
CFR Cyclic flow reduction
DRF Dose Reduction Factor
FECR Faecal Egg Count Reduction
FECRT Faecal egg count reduction test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bone reduction procedure
    °ñ Á¦°Å¼ú
  • closed reduction
    ºñ°üÇ÷Àû °ñ Á¤º¹¼ú
  • disc dislocation with reduction
    Á¤º¹¼º °üÀý¿øÆÇ ÀüÀ§
  • disc displacement with reduction
    Á¤º¹¼º °üÀý¿øÆÇ º¯À§
    µ¿ÀǾî=reducing disc. ±³µÎ°£À§¿¡¼­ ÃøµÎÇϾǰüÀýÀÇ °üÀý¿øÆÇÀÌ º¯À§µÈ °ÍÀ¸·Î¼­ ÇÏ¾Ç °úµÎÀÇ È°Áֿ°ú ȸÀü¿îµ¿ µ¿¾È ÇÏ¾Ç °úµÎ°¡ °üÀý ¿øÆÇ°ú Á¤»óÀûÀÎ ÇØºÎÇÐÀû °ü°è¸¦ ÀçÈ®¸³ÇÑ´Ù.
  • disk displacement without reduction
    ºñÁ¤º¹¼º °üÀý¿øÆÇ º¯À§
  • distal wedge reduction
    ¿ø½É ½û±âÇü ÀýÁ¦
  • functional dislocation with reduction
    Á¤º¹¼º ±â´ÉÀû ÀüÀ§
  • interproximal reduction
    Ä¡°£ »èÁ¦
  • nitrate reduction test
    Áú»ê¿° ȯ¿ø ½ÃÇè
  • oxidation reduction system
    »êÈ­ ȯ¿ø°è
  • reduction of fracture
    °ñÀý Á¤º¹
  • silver reduction method
    Àº ȯ¿ø¹ý
  • TMJ-ID with reduction
    Á¤º¹¼º ¾Ç°üÀý ³»Àå
    ¾Ç°üÀý ³»ÀåÀÇ Ãʱ⠴ܰè·Î ¿Õº¹¼º °üÀýÀ½ÀÌ Æ¯Â¡À¸·Î ³ªÅ¸³­´Ù. ÇÏ¾Ç ¿îµ¿ ¹üÀ§´Â ´ë°³ Á¤»óÀÌ´Ù.
  • anesthetic area
    ¸¶Ãë ¿ª
  • anterior amygdaloid area
    ¾Õ Æíµµ ±¸¿ª
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acetyl reduction assay <investigation> A technique for measuring the nitrogen fixation activity in photosynthetic organisms. It uses a flame ionisation detector and a gas chromatography apparatus to determine the reduction of acetylene to ethylene by the enzyme nitrogenase.
(06 May 1997)
reduction <orthopaedics, surgery> The correction of a fracture, dislocation or hernia.
(18 Nov 1997)
reduction deformity Congenital absence or attenuation of one or more body parts; usually of the limbs or limb components.
(05 Mar 2000)
reduction division The first cell division in meiosis, the process by which germ cells are formed. A unique event in which the chromosome number is reduced from diploid (46 chromosomes) to haploid (23 chromosomes). Also called first meiotic division or first meiosis.
(12 Dec 1998)
reduction en masse Reduction of hernial sac and contents, so that intestinal obstruction is still present.
(05 Mar 2000)
reduction mammaplasty Plastic surgery of the breast to reduce its size and (frequently) to improve its shape and position.
(05 Mar 2000)
reduction nucleus A nucleus that degenerates in the cell during the changes incident to fertilization.
(05 Mar 2000)
reduction of chromosomes The process during meiosis whereby one member of each homologous pair of chromosomes is distributed to a sperm or ovum; the diploid set of chromosomes (46 in humans) is thus reduced to the haploid set in each gamete; union of the sperm and ovum then restores the diploid or somatic number in the one-cell zygote.
(05 Mar 2000)
reduction phase The stage of nuclear changes in the sexual cells during which reduction of the chromosomes takes place; it embraces the cell generations of the spermatocytes and oocytes.
Synonym: reduction phase.
(05 Mar 2000)
reduction potential The inherent tendency of a compound to act as an electron donor or an electron acceptor. Measured in volts.
(09 Oct 1997)
risk reduction Techniques used to reduce your chances of getting a certain cancer. For example: reducing your dietary fat may help prevent breast cancer.
(09 Oct 1997)
closed reduction The physical manipulation of a joint or bone externally (without making a surgical incision) to affect a joint relocation or more proper anatomic alignment of broken bone fragments. Closed reductions are often performed using intravenous analgesics, local anaesthetic nerve blocks or regional anaesthesia.
(27 Sep 1997)
closed reduction of fractures Reduction by manipulation of bone, without incision in the skin.
(05 Mar 2000)
Motulsky dye reduction test A test for glucose-6-phosphate dehydrogenase deficiency in the blood, using a mixture of brilliant cresyl blue, glucose-6-phosphate, and NADP.
(05 Mar 2000)
pregnancy reduction, multifetal Selective abortion of one or more embryos or foetuses in a multiple gestation pregnancy. The usual goal is to improve the outcome for the remaining embryos or foetuses.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduction
    °¨¼Ò
  • data reduction
    (Àü»ê)µ¥ÀÌÅÍ Á¤¸®(¾ÐÃà)
  • reduction
    Ãà¼Ò;»è°¨;°¨¼Ò;ÇÒÀÎ;Ãà»ç;Ã൵;º¯Çü;Á¤¸®;´Ü¼øÈ­;ÀûÇÕ;ÀûÀÀ;Ç׺¹;±Í¼ø;ÇÔ¶ô;¾àºÐ;ȯ»ê;ȯ¿ø¹ý;º¹À§;Á¤º¹(¼ú);ȯ¿ø¹ý;°³°Ý¹ý;¼öÁ¤(°üÃøÁßÀÇ ¿ÀÂ÷ÀÇ º¸Á¤);°¨¼öºÐ¿­
  • reduction division
    °¨¼ö ºÐ¿­
  • reduction formula
    ȯ¿ø(ȯ»ê) °ø½Ä
  • reduction gear
    °¨¼Ó ±â¾î
  • tax reduction
    °¨¼¼
  • area
    ¸éÀû,Áö¿ª
  • Special Area
    Ưº°Áö±¸
  • area
    ¸éÀû;°ø°£;Áö¿ª;Áö¹æ;¿µ¿ª;°øÁö;¹üÀ§;ÁöÇÏ½Ç ÃâÀÔ±¸
  • area code
    ½Ã¿Ü±¹¹ø(¹Ì±¹Àº ¼ýÀÚ 3ÀÚ¸®)
  • blanket area
    (¹æ¼Û±¹ ÁÖº¯ÀÇ)³­Ã»±¸¿ª
  • catchment area (basin)
    (°­.¸øÀÇ) Áý¼ö Áö¿ª;(Çб³.º´¿ø.°üû µîÀÇ)´ã´ç(°üÇÒ)±¸¿ª
  • corps area
    ±º´Ü ÀÛÀü Áö¿ª;±º°ü±¸ 
  • culture area
    (°øÅëÀÇ)¹®È­ ¿µ¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á